3.5(top 4%)
Impact Factor
3.8(top 4%)
extended IF
137(top 2%)
H-Index
2.1K
authors
6.5K
papers
154K
citations
8.7K
citing journals
72.6K
citing authors

Most Cited Articles of Clinical Therapeutics

TitleYearCitations
A systematic review of the associations between dose regimens and medication compliance20011.7K
Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice1999609
Recognition and treatment of hyponatremia in acutely ill hospitalized patients2007551
Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity2000489
Capecitabine: a review2005456
Immunogenicity of therapeutic proteins: clinical implications and future prospects2002438
Evaluating quality-of-life and health status instruments: development of scientific review criteria1996435
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study2006431
The cost of treating community-acquired pneumonia1998421
Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies2006392
The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma2015360
Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir2001358
Childhood obesity: a review of increased risk for physical and psychological comorbidities2013353
Trastuzumab, a recombinant DNA-derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancer1999344
Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials2003335
Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study2007327
Gut-Microbiota-Brain Axis and Its Effect on Neuropsychiatric Disorders With Suspected Immune Dysregulation2015325
Current Challenges in Cancer Treatment2016318
Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: a randomized, placebo-controlled study. The Pioglitazone 027 Study Group2000314
A review of the chemistry, biological action, and clinical applications of anabolic-androgenic steroids2001301
Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study2008294
Aripiprazole: a comprehensive review of its pharmacology, clinical efficacy, and tolerability2004281
A review of diabetes treatment adherence and the association with clinical and economic outcomes2011280
Predictors of medication adherence in the elderly1998277
Lapatinib: a dual inhibitor of human epidermal growth factor receptor tyrosine kinases2008274